Argá Medtech Initiates First-in-Human Trial to Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation
Acute procedural success achieved in all patients using a novel pulsed field ablation (PFA) sine waveform and configurable catheter. EPALINGES, Switzerland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Argá Medtech
Source: finanznachrichten.de